All News about Proqr Therapeutics![]() ![]() Via GlobeNewswire
![]() ![]() ![]()
4 Analysts Have This to Say About ProQR Therapeutics
August 04, 2023
Via Benzinga
![]()
Analyst Ratings for ProQR Therapeutics
May 17, 2023
Via Benzinga
![]()
Recap: ProQR Therapeutics Q1 Earnings
May 16, 2023
Via Benzinga
![]() ![]() ![]() ![]() ![]() Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]() ![]()
US Stocks Lower; Dow Falls Over 50 Points
November 27, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![]()
Bluebird Bio To Rally Around 267%? Here Are 10 Top Analyst Forecasts For Wednesday
November 08, 2023
Via Benzinga
![]()
ProQR Announces Third Quarter 2023 Operating and Financial Results
November 07, 2023
Via GlobeNewswire
![]() ![]() ![]()
ProQR Therapeutics Provides Update on Ophthalmic Assets
September 27, 2023
Via GlobeNewswire
![]() ![]() Via GlobeNewswire
![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |